11,584 Shares in Prestige Consumer Healthcare Inc. $PBH Acquired by Callan Family Office LLC

Callan Family Office LLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 11,584 shares of the company’s stock, valued at approximately $548,000.

Other institutional investors also recently bought and sold shares of the company. Leeward Investments LLC MA raised its stake in shares of Prestige Consumer Healthcare by 23.3% in the 4th quarter. Leeward Investments LLC MA now owns 387,321 shares of the company’s stock valued at $23,894,000 after acquiring an additional 73,162 shares during the period. Legato Capital Management LLC boosted its position in Prestige Consumer Healthcare by 532.4% during the 4th quarter. Legato Capital Management LLC now owns 27,774 shares of the company’s stock worth $1,713,000 after purchasing an additional 23,382 shares during the period. Brandes Investment Partners LP increased its holdings in Prestige Consumer Healthcare by 93.2% in the 4th quarter. Brandes Investment Partners LP now owns 606,737 shares of the company’s stock valued at $37,430,000 after purchasing an additional 292,744 shares in the last quarter. Bessemer Group Inc. raised its position in Prestige Consumer Healthcare by 20.9% in the first quarter. Bessemer Group Inc. now owns 374,691 shares of the company’s stock valued at $22,207,000 after purchasing an additional 64,760 shares during the period. Finally, Royce & Associates LP raised its position in Prestige Consumer Healthcare by 68.3% in the fourth quarter. Royce & Associates LP now owns 97,750 shares of the company’s stock valued at $6,030,000 after purchasing an additional 39,685 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

PBH opened at $51.38 on Wednesday. The company has a market capitalization of $2.43 billion, a P/E ratio of 14.39, a PEG ratio of 1.63 and a beta of 0.34. The company has a 50-day moving average of $49.90 and a 200-day moving average of $54.84. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.99 and a current ratio of 3.23. Prestige Consumer Healthcare Inc. has a 1-year low of $42.62 and a 1-year high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.89 by $0.09. The business had revenue of $265.71 million for the quarter, compared to analysts’ expectations of $253.02 million. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Oppenheimer cut Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 14th. Weiss Ratings downgraded Prestige Consumer Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, June 25th. Canaccord Genuity Group reduced their price target on Prestige Consumer Healthcare from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. Finally, Zacks Research raised Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, August 10th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $70.75.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).